MORE safety concerns with dronedarone (Multaq)

October 2011

See the December 2011 completed FDA safety review of Multaq (dronedarone)

There are MORE safety concerns with dronedarone (Multaq).

This time it has to do with the TYPE of atrial fibrillation.

Multaq improves CV outcomes in some patients with PAROXYSMAL or PERSISTENT atrial fib. These resolve spontaneously or with cardioversion.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Anticoagulants controversy over which ORAL anticoagulant to use to prevent strokes in patients with atrial fibrillation
Antidepressants citalopram doses should not exceed 40 mg/day for anyone...or 20 mg/day for most patients over age 60
Antidepressants Reps are filling up sample closets, hoping prescribers will use Deplin to improve the efficacy of antidepressants
Respiratory & Allergy chronic azithromycin to PREVENT recurrent COPD exacerbations
Influenza the same flu strains as last year, the first INTRADERMAL flu vaccine, and a new Tamiflu suspension
Opioids two new opioid formulations, Oxecta and Lazanda
Women's Health tighter and more aggressive control of hypothyroidism before and during pregnancy
Antipsychotics serious allergic reactions to the antipsychotic, Saphris (asenapine)
Cardiology MORE safety concerns with dronedarone (Multaq)
Geriatrics manage elderly dementia patients who have behavior issues
Corticosteroids whether hyperglycemia can occur with non-oral corticosteroids
Interactions Computer alerts about an interaction between oral potassium chloride (Micro-K, etc) and anticholinergics are causing confusion